This idea is further supported by reports that (a) lipocalins such as LCN2 and several chemokines are significantly overexpressed in human oral cancers [17, 24, 25] and (b) these and related targets appear to be “druggable” [23, 28, 29]. Here, LCN2 is linked to lip and oral cavity carcinoma.